While posttranslational modifications of PSMD1 have been shown to modulate its effects on ubiquitination [11], the role of PSMD1 in HCC progression and its impact on immunotherapy remain unexplored. The gene discussed is PSMD1; the disease is hepatocellular carcinoma.